These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30621958)

  • 1. Cardiomyopathy and Heart Failure in Patients With HIV Infection.
    Savvoulidis P; Butler J; Kalogeropoulos A
    Can J Cardiol; 2019 Mar; 35(3):299-309. PubMed ID: 30621958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Immunodeficiency Virus Infection-Associated Cardiomyopathy and Heart Failure.
    Papamanoli A; Muncan B; Yoo J; Psevdos G; Kalogeropoulos AP
    J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36573732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart health in the age of highly active antiretroviral therapy: a review of HIV cardiomyopathy.
    Belkin MN; Uriel N
    Curr Opin Cardiol; 2018 May; 33(3):317-324. PubMed ID: 29543672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial disease in human immunodeficiency virus (HIV) infection: a review.
    Sani MU
    Wien Klin Wochenschr; 2008; 120(3-4):77-87. PubMed ID: 18322768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology and pathophysiology of heart failure in people with HIV.
    Choi H; Dey AK; Sharma G; Bhoite R; Burkholder G; Fedson S; Jneid H
    Heart Fail Rev; 2021 May; 26(3):497-505. PubMed ID: 33619685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure in persons living with HIV infection.
    Hsue PY; Waters DD
    Curr Opin HIV AIDS; 2017 Nov; 12(6):534-539. PubMed ID: 28863015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dysfunction in human immunodeficiency virus infection.
    Cade WT
    J Cardiometab Syndr; 2008; 3(2):83-7. PubMed ID: 18453807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds.
    Lumsden RH; Bloomfield GS
    Biomed Res Int; 2016; 2016():8196560. PubMed ID: 26885518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.
    Sinha A; Feinstein M
    Prog Cardiovasc Dis; 2020; 63(2):134-141. PubMed ID: 31987806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.
    Lipshultz SE; Wilkinson JD; Thompson B; Cheng I; Briston DA; Shearer WT; Orav EJ; Westphal JA; Miller TL; Colan SD;
    J Am Coll Cardiol; 2017 Oct; 70(18):2240-2247. PubMed ID: 29073951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study.
    Butler J; Kalogeropoulos AP; Anstrom KJ; Hsue PY; Kim RJ; Scherzer R; Shah SJ; Shah SH; Velazquez EJ; Hernandez AF; Desvigne-Nickens P; Braunwald E
    J Card Fail; 2018 Apr; 24(4):255-265. PubMed ID: 29482027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapy.
    Aliku TO; Lubega S; Lwabi P
    Afr Health Sci; 2015 Mar; 15(1):288-92. PubMed ID: 25834562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of HAART in infants and children of HIV-infected mothers.
    Zareba KM; Lavigne JE; Lipshultz SE
    Cardiovasc Toxicol; 2004; 4(3):271-9. PubMed ID: 15470274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
    MacArthur RD; DuPont HL
    Clin Infect Dis; 2012 Sep; 55(6):860-7. PubMed ID: 22700829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of HIV-associated cardiomyopathy.
    Barbaro G; Lipshultz SE
    Ann N Y Acad Sci; 2001 Nov; 946():57-81. PubMed ID: 11762996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
    Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
    Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era.
    Cerrato E; D'Ascenzo F; Biondi-Zoccai G; Calcagno A; Frea S; Grosso Marra W; Castagno D; Omedè P; Quadri G; Sciuto F; Presutti D; Frati G; Bonora S; Moretti C; Gaita F
    Eur Heart J; 2013 May; 34(19):1432-6. PubMed ID: 23335603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.